Hernández CJR, Torres MSA, Hernández CEM

Language: Spanish
References: 16
Page:
PDF size: 169.30 Kb.

ABSTRACT

COVID-19 disease began in December 2019, becoming known as a pandemic by the World Health Organization in March 2020. The U.S. Center for Disease Control and Prevention issues alert on an acute multisystem inflammatory illness in children, and called it Pediatric Multisystem Inflammatory Syndrome temporally associated with SARS-CoV-2 or MIS-C. It manifests in children and adolescents between 0 and 19 years of age, who also present fever for more than 3 days, marked elevation of acute phase reactants, associated with mucocutaneous inflammation, hypotension or shock, cardiac dysfunction, coagulopathies, or acute gastrointestinal symptoms. The diagnosis of this pathology is made through clinical history, symptomatology, and laboratory changes. It presents similar characteristics to other diseases with inflammatory processes such as Kawasaki disease, toxic shock syndrome, and macrophage activation syndrome or hemophagocytic syndrome. The appropriate management is unknown, but several treatments have been proposed that have shown improvement of the clinical picture of patients, such as the administration of intravenous immunoglobulins, corticosteroids and aspirin, among other specific treatments.

REFERENCES

1. Ulloa-Gutiérrez R, Ivankovich-Escoto G, Yamazaki-Nakashimada MA. Síndrome inflamatorio multisistémico asociado a COVID-19 en niños y adolescentes: un llamado al diagnóstico. Rev Chil infectología. 2020;37(3):199-201.

2. Gil R, Jacinto L, Lemus P, Barillas G, Velasquez S, Recinos F. Diagnóstico Clínico y Manejo de Pacientes Pediátricos sospechos y confirmados de COVID-19. 2020. p. 1-45.

3. Torretti JPT, Gallardo MO. El COVID-19 y las 3 “P”: Pandemia, Pediatría y su impacto en el País. Rev Chil Pediatr. 2020;91(3):322-3.

4. De Coll-Vela LE, Zamudio-Aquise MK, Nuñez-Paucar H, Bernal-Mancilla RR, Schult-Montoya SC, Paz MCD La, et al. COVID-19–associated multisystem inflammatory syndrome in children: Case series at a pediatric hospital in Peru. Rev Peru Med Exp Salud Publica. 2020;37(3):559-65.

5. Mónica Patricia Velásquez Méndez, Zapata LJH. SÍNDROME INFLAMATORIO MULTISISTÉMICO PEDIÁTRICO: ¿VIEJO CONOCIDO O NUEVO POR CONOCER? Soc Colomb Pediatría. 2017;(3).

6. Ministerio de Salud Chile. Protocolo Síndrome Inflamatorio Multisistémico en niños, niñas y adolescentes con SARS-CoV-2. Ministerio de Salud. Gobierno de Chile. 2020. p. 1-17.

7. Comité Nacional de Pediatría General Ambulatoria. Recomendaciones para la atención del paciente pediátrico con infección por SARS-CoV-2. Soc Argentina Pediatría. 2020;49-63.

8. Márquez-Aguirre MP, Gutiérrez-Hernández A, Lizárraga-López SL, Muñoz-Ramírez CM, Ventura-Gómez ST, del Socorro Zárate-Castañón PM, et al. Clinical spectrum of COVID-19 in the pediatric patient. Acta Pediatr Mex. 2020;41(4):S64-71.

9. Bustos R. Síndrome inflamatorio multisistémico asociado con SARS-CoV-2 en pediatría. Rev Chil Pediatría. 2020;9(3):393-8.

10. Tagarro A. Evolución De La Pandemia Por SARS COVID-19 En Población Pediátrica. Rev Esp Salud Publica. 2020;1-3.

11. Gutierrez O, Romero SP. Síndrome inflamatorio multisistémico en niños asociado al SARS-CoV-2. Pediatría (Asunción). 2020;47(2):103-7.

12. Hernández J, Sanguinetty N, Quintero B, Mavárez A. Síndrome Multisistémico Inflamatorio Pediátrico temporalmente asociado a SARS-CoV-2: un nuevo reto a la luz de la evidencia. Rev Investig Desarro. 2020;12(1):51-66.

13. Torres MTL, Molina SER, Reyes LER, Lagos LL, Flores AMD, Pediatra KLBA, et al. PROTOCOLO DE ATENCIÓN AL PACIENTE PEDIÁTRICO CON SOSPECHA O INFECCIÓN CONFIRMADA POR SARS-COV-2 (COVID-19). Vol. 2. 2020. p. 1-19.

14. Tamara Velásquez C, María Adela Godoy R, Francisco Prado A. Pediatric multisystem inflammatory syndrome temporally associated with sars-cov-2: How do we deal with an unpredictable enemy? Rev Chil Pediatr. 2020;91(4):644-5.

15. Concha I, Fernández C, Hirsch T, Prado F, Morales V, Pezoa A. Diagnosis and treatment of pediatric patients with covid-19 infectious disease at the emergency room. A guideline for this pandemia. Rev Chil Pediatr. 2020;91(7):1-8.

16. Feldstein LR, Rose EB, Horwitz SM, Collins JP, Newhams MM, Son MBF, et al. Multisystem Inflammatory Syndrome in U.S. Children and Adolescents. N Engl J Med. 2020;383(4):334-46.